Need to Recalibrate Research Outcomes in Alzheimer's Disease: Focus on Neuropsychiatric Symptoms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Need to Recalibrate Research Outcomes in Alzheimer's Disease: Focus on Neuropsychiatric Symptoms

Published:2017-07-06 Issue:9 Volume:65 Page:2071-2073
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Canevelli Marco¹,Cesari Matteo²³^ORCID,Lucchini Flaminia¹,Valletta Martina¹,Sabino Michele¹,Lacorte Eleonora⁴,Vanacore Nicola⁴,Bruno Giuseppe¹

Affiliation:

1. Department of Neurology and Psychiatry; “Sapienza” University of Rome; Rome Italy

2. Gérontopôle; Centre Hospitalier Universitaire de Toulouse; Toulouse France

3. Université de Toulouse III Paul Sabatier; Toulouse France

4. National Centre for Epidemiology, Surveillance, and Health Promotion; National Institute of Health; Rome Italy

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgs.14989/fullpdf

Reference10 articles.

1. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study;Lyketsos;JAMA,2002

2. The contribution of neuropsychiatric symptoms to the cost of dementia care;Herrmann;Int J Geriatr Psychiatry,2006

3. Management of older adults with dementia who present to emergency services with neuropsychiatric symptoms;Silwanowicz;Int J Geriatr Psychiatry,2016

4. The incremental direct costs associated with behavioral symptoms in AD;Murman;Neurology,2002

5. Defeating Alzheimer's disease and other dementias: A priority for European science and society;Winblad;Lancet Neurol,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of motor dysfunction on neuropsychiatric symptom profile in patients with autopsy-confirmed Alzheimer’s disease;International Review of Psychiatry;2024-04-02

2. Depression and Suicide Risk in Mild Cognitive Impairment: The Role of Alzheimer's Disease Biomarkers;PSICOTHEMA;2022

3. Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease lead to depression?;Expert Opinion on Drug Metabolism & Toxicology;2021-06-10

4. Ongoing research protocols for the pharmacological treatment of neuropsychiatric symptoms in dementia;Journal of Frailty & Aging;2020

5. Do anti-amyloid-β drugs affect neuropsychiatric status in Alzheimer’s disease patients?;Ageing Research Reviews;2019-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3